1. High number of INS relapses in childhood is a risk factor for recurrences in adulthood. 2. INS relapses in childhood do not preclude active professional life in adulthood.
P < 0.001 (Fisher exact probability test).c l i n i c a l i n v e s t i g a t i o n AM _ Zurowska et al.: Mild Alport syndrome due to founder COL4A5 p.G624D AM _ Zurowska et al.: Mild Alport syndrome due to founder COL4A5 p.G624D c l i n i c a l i n v e s t i g a t i o n Kidney International (2021) -, ---AM _ Zurowska et al.: Mild Alport syndrome due to founder COL4A5 p.G624Dc l i n i c a l i n v e s t i g a t i o n
1-O-(indole-3-acetyl)-b-D-glucose: myo-inositol indoleacetyl transferase (IA-myo-inositol synthase) is an important enzyme in IAA metabolism. This enzyme catalyses the transfer of the indole acetyl (IA) moiety from 1-O-(indole-3-acetyl)-b-Dglucose to myo-inositol to form IA-myo-inositol and glucose. IA-myo-inositol synthase was purified to an electrophoretically homogenous state from maize liquid endosperm by fractionation with ammonium sulphate, anion-exchange, adsorption on hydroxylapatite, affinity chromatography on ConA-Sepharose, preparative PAGE and isoelectric focusing. We thus obtained two enzyme preparations which differ in their R f on 8% polyacrylamide gel. The preparation of R f 0.36 contained a single 56.4 kDa polypeptide, whereas the preparation of R f 0.39 consisted of two polypeptides of 56.4 and 53.5 kDa. Both purified preparations of IAInos synthase also exhibited the activity of an IAInos hydrolase, showing that the dual activity was associated with a single protein. Results of gel filtration and analytical SDS-PAGE suggest that the native enzyme exists as both a monomeric (65 kDa) and homo-or heterodimeric form (110-130 kDa). Analysis of peptide maps and amino acid sequences of two 21 amino-acid peptides showed that polypeptides of 56.4 and 53.5 kDa have the same primary structure and that the 3 kDa difference in molecular mass is probably caused by different glycosylation levels. Comparison of this partial and internal amino acid sequence with sequences of other plant acyltransferases indicated similarity to several proteins which belonged to the serine carboxypeptidase-like (SCPL) acyltransferase family.
Summary UDP-glycosyltransferases (GTases, UGT) catalyze the transfer of the sugar moiety from the uridine-diphosphate-activated monosaccharide (e.g. uridine-diphosphate-5’-glucose, UDPG) molecule to the specific acceptor. Glycosides contain aglycons attached by a β-glycosidic bond to C1 of the saccharide moiety. Glycosylation is one of the mechanisms maintaining cellular homeostasis through the regulation of the level, biological activity, and subcellular distribution of the glycosylated compounds. The glycosides play various functions in plant cells, such as high-energy donors, or signalling molecules, and are involved in biosynthesis of cell walls. Plant cells exhibit structural and functional diversity of UGT proteins. The Arabidopsis thaliana genome contains more than 100 genes encoding GTases, which belong to 91 families, and are deposited in the CAZY (Carbohydrate Active enzyme) database (www. cazy.org/GlycosylTransferases.html). The largest UGT1 class is divided into 14 subfamilies (A-N), and includes proteins containing highly conserved 44-amino acid PSPG (Plant Secondary Product Glycosyltransferase) motif at the C-terminus. The PSPG motif is involved in the binding of UDP-sugar donors to the enzyme. UGT1’s catalyze the biosynthesis of both ester-type and ether-type conjugates of plant hormones (phytohormones). Conjugation of the phytohormones is an important mechanism that regulates the concentration of physiological active hormone levels during growth and development of plants. Glycoconjugation of phytohormones is widespread in the plant kingdom and all known phytohormones are able to form these conjugates. Most plant hormone conjugates do not indicate physiological activity, but rather are involved in transport, storage and degradation of the phytohormones. UDPG-dependent glycosyltransferases possess high substrate specificity, even within a given class of phytohormones. In many cases, the phenotype of plants is strongly affected by loss-of-function mutations in UGT genes. In this paper, advances in the isolation and characterization of glycosyltransferases of all plant hormones: auxin, brassinosteroids, cytokinin, gibberellin, abscisic acid, jasmonates, and salicylate is described
Immature seeds of some dicotyledonous plants contain IAGlc synthase catalysing the synthesis of 1-O-IAGlc. This enzyme activity is comparable with 1-O-IAGlc synthase activity investigated earlier in liquid endosperm of Zea mays. Polyclonal antibodies against maize 1-O-IAGlc synthase cross-react with partially purified 1-O-IAGlc synthase from immature pea and rape seeds. Single immunoreactive bands were observed at a locus corresponding to 45.7 kDa and 43.7 kDa from pea and rape enzyme preparations, respectively, unlike that from the 50 kDa molecular mass of the maize enzyme. It was also observed that some high molecular weight compounds of pea seeds are labelled in vivo by [(14)C] IAA, and unlabelled 1-O-IAGlc inhibits that labelling. In immature pea seeds 43-49.8% of the IAA-modified high molecular weight compounds, obtained after ultracentrifugation, was found in the soluble fraction and 50.1-57% in the insoluble fraction. Ester-linked IAA accounted for about 6-9% and 38-45.6% in soluble and insoluble material, respectively, estimated after hydrolysis in 1 N NaOH. Enzymatic hydrolysis of IAA-labelled high molecular weight compounds gives free IAA and compound(s) corresponding to IAGlc isomers. These results suggest that 1-O-IAGlc synthesized in legume seeds may be used for the modification of some high molecular weight compounds.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.